Zobrazeno 1 - 10
of 91
pro vyhledávání: '"D. MIDDLEMISS"'
Autor:
Prateek Sharma, James R. J. Haycocks, Alistair D. Middlemiss, Rachel A. Kettles, Laura E. Sellars, Vito Ricci, Laura J. V. Piddock, David C. Grainger
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
Transcription factors MarR and MarA confer multidrug resistance in enteric bacteria by modulating efflux pump and porin expression. Here, Sharma et al. show that MarA also upregulates genes required for lipid trafficking and DNA repair, thus reducing
Externí odkaz:
https://doaj.org/article/4669c1bf8a8f4a01bd835687185dcfd1
Autor:
Alistair D. Middlemiss, Emily A. Warman, David Forrest, James R. J. Haycocks, David C. Grainger
Publikováno v:
Microbiology. 169
Transcription of the DNA template, to generate an RNA message, is the first step in gene expression. The process initiates at DNA sequences called promoters. Conventionally, promoters have been considered to drive transcription in a specific directio
Autor:
Alistair D. Middlemiss, James R. J. Haycocks, Anne M. Stringer, Laura J. V. Piddock, Joseph T. Wade, David C. Grainger
Publikováno v:
Microbiology. 169
The closely related transcription factors MarA, SoxS, Rob and RamA control overlapping stress responses in many enteric bacteria. Furthermore, constitutive expression of such regulators is linked to clinical antibiotic resistance. In this work we hav
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nishi Gupta, Arthur D. Middlemiss
Publikováno v:
Journal of Financial Crime. 14:138-149
PurposeThis paper aims to illustrate by example the value of interagency cooperation between US and international law enforcement and regulatory agencies.Design/methodology/approachGeneral review of post‐9/11 criminal cases brought by the Manhattan
Autor:
D B, Judd, M D, Dowle, D, Middlemiss, D I, Scopes, B C, Ross, T I, Jack, M, Pass, E, Tranquillini, J E, Hobson, T A, Panchal
Publikováno v:
Journal of Medicinal Chemistry. 37:3108-3120
We have identified GR138950, a potent antagonist of the angiotensin II receptor with high oral bioavailability, as our second drug candidate to GR117289. Using GR117289, a compound with moderate bioavailability (20%) in man as a lead, we pursued a st
Publikováno v:
ChemInform. 27
Autor:
A, Hilditch, A A, Hunt, A, Travers, J, Polley, G M, Drew, D, Middlemiss, D B, Judd, B C, Ross, M J, Robertson
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 272(2)
The antagonist activity of GR138950 (1-[[3-bromo-2-[2-[[(trifluoromethyl)sulphonyl]amino]phenyl]-5- benzofuranyl]methyl]-4-cyclopropyl-2-ethyl-1H-imidazole-5-carboxamide) was investigated at angiotensin AT1 receptors and AT2 receptors in vitro and on
Autor:
Stephen G. Ball, Kwok-Tao Pun, Philip Warburton, Anthony J. Balmforth, D. Middlemiss, A. J. Aylett, Susan E. Bryson, G.M. Drew
Publikováno v:
British journal of pharmacology. 112(1)
1. Currently available antagonists and agonists cannot distinguish between angiotensin AT1 receptor subtypes. 2. We synthesized a series of compounds selected on the basis of having the most diverse structural features with respect to losartan (DuP75